Global Dialysis Perspective: Argentina

Orías, Marcelo; Díez, Guillermo Javier Rosa

doi:10.34067/kid.0001222019

Cited by 5 publications

(8 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In South Africa, the prevalence of AVF, AVG, and CVC was 51, 7, and 39%, respectively, in 2017 [30]. In Argentina, the prevalence of AVF, AVG, and CVC was Thurlow/Joshi/Yan/Norris/Agodoa/ Yuan/Nee Am J Nephrol 2021;52:98-107 102 DOI: 10.1159/000514550 70, 15, and 15%, respectively, in 2018 [31]. In Vietnam, the prevalence of AVF, AVG, and CVC was >95, 4, and 1%, respectively, in 2018 [32].…”

Section: Vascular Accessmentioning

confidence: 99%

Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy

et al. 2021

View full text Add to dashboard Cite

Background: The global epidemiology of end-stage kidney disease (ESKD) reflects each nation’s unique genetic, environmental, lifestyle, and sociodemographic characteristics. The response to ESKD, particularly regarding kidney replacement therapy (KRT), depends on local disease burden, culture, and socioeconomics. Here, we explore geographic variation and global trends in ESKD incidence and prevalence and examine variations in KRT modality, practice patterns, and mortality. We conclude with a discussion on disparities in access to KRT and strategies to reduce ESKD global burden and to improve access to treatment in low- and middle-income countries (LMICs). Summary: From 2003 to 2016, incidence rates of treated ESKD were relatively stable in many higher income countries but rose substantially predominantly in East and Southeast Asia. The prevalence of treated ESKD has increased worldwide, likely due to improving ESKD survival, population demographic shifts, higher prevalence of ESKD risk factors, and increasing KRT access in countries with growing economies. Unadjusted 5-year survival of ESKD patients on KRT was 41% in the USA, 48% in Europe, and 60% in Japan. Dialysis is the predominant KRT in most countries, with hemodialysis being the most common modality. Variations in dialysis practice patterns account for some of the differences in survival outcomes globally. Worldwide, there is a greater prevalence of KRT at higher income levels, and the number of people who die prematurely because of lack of KRT access is estimated at up to 3 times higher than the number who receive treatment. Key Messages: Many people worldwide in need of KRT as a life-sustaining treatment do not receive it, mostly in LMICs where health care resources are severely limited. This large treatment gap demands a focus on population-based prevention strategies and development of affordable and cost-effective KRT. Achieving global equity in KRT access will require concerted efforts in advocating effective public policy, health care delivery, workforce capacity, education, research, and support from the government, private sector, nongovernmental, and professional organizations.

show abstract

Section: Vascular Accessmentioning

confidence: 99%

Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The Kidney360 Global Dialysis Perspective series launched in 2020 and showcases how dialysis is practiced, delivered, and financed in different countries across the world. To date, we have featured perspectives from 17 countries in 6 continents: Africa (Senegal, South Africa); Asia (India, Israel, Japan, Korea, Singapore, Thailand, Vietnam); Australia; Europe (Spain); North America (Canada, Mexico, United States); and South America (Argentina, Brazil, Guatemala) [4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20] . Authors of each global perspective were asked to report standard information about their dialysis populations, including general characteristics of the dialysis system and its treatments such as percentage of patients by dialysis modality; dialysis unit financing (for profit vs. non-profit); reimbursement (public or private insurance, or self-pay); unit location (hospital vs. free standing); staffing (proportion of nurses vs. patient care technicians and nurse to patient ratios); hemodialysis frequency and session length; and frequency of nephrologist visits.…”

Section: Introductionmentioning

confidence: 99%

Dialysis Care around the World: A Global Perspectives Series

2021

View full text Add to dashboard Cite

Worldwide, end stage kidney disease prevalence has steadily increased, with the greatest proportional increases occurring in lower- and middle-income countries. Although dialysis is a life-saving therapy, it is also extraordinarily expensive, so its use is limited in lower income countries with less resources available for healthcare. The Kidney360 Global Dialysis Perspective series launched in 2020 and showcases how dialysis is practiced, delivered, and financed in different countries across the world. To date, we have featured perspectives from 17 countries in 6 continents: Africa (Senegal, South Africa); Asia (India, Israel, Japan, Korea, Singapore, Thailand, Vietnam); Australia; Europe (Spain); North America (Canada, Mexico, United States); and South America (Argentina, Brazil, Guatemala).

show abstract

“…As per the latest national health and nutrition surveys conducted across the LatAm countries, the prevalence of CKD among the adult patient population oscillates between 7% and 13%. 3 , 21 , 22 , 23 , 24 , 25 , 26 , 27 Argentina was ranked first (12.7%), followed by Panama (12%), Ecuador, and Mexico (11% each). 3 , 23 , 24 , 27 Colombia was least affected with CKD, 28 with fewer cases registered in the past 5 years (1.7%).…”

Section: Presentation and Discussionmentioning

confidence: 99%